Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$1.74 | $1.14 | -$0.10 |
| Q2 2026 | 1 | -$0.40 | -$0.13 | -$0.25 |
| Q3 2026 | 1 | -$0.40 | -$0.13 | -$0.26 |
| Q4 2026 | 1 | $0.11 | $0.35 | $0.22 |
Zymeworks BC Inc last posted its earnings results on Thursday, November 6th, 2025. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.3 by $0.04. The company had revenue of 27.61 M for the quarter and had revenue of 76.30 M for the year. Zymeworks BC Inc has generated $-2 earnings per share over the last year ($-1.62 diluted earnings per share) and currently has a price-to-earnings ratio of -26.89. Zymeworks BC Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | -$0.30 | -$0.26 | 0.04 | $29.91 M | $27.61 M |
| 08/07/2025 | Q2 2025 | -$0.52 | $0.03 | 0.55 | $17.25 M | $48.73 M |
| 05/08/2025 | Q1 2025 | -$0.45 | -$0.30 | 0.15 | N/A | $27.11 M |
| 03/05/2025 | Q4 2024 | $0.01 | -$0.31 | -0.32 | N/A | $31.03 M |
| 10/31/2024 | Q3 2024 | -$0.40 | -$0.39 | 0.01 | $17.90 M | $16.00 M |
| 08/01/2024 | Q2 2024 | -$0.42 | -$0.49 | -0.07 | $11.94 M | $19.24 M |
| 05/02/2024 | Q1 2024 | -$0.31 | -$0.42 | -0.11 | N/A | $10.03 M |
| 03/06/2024 | Q4 2023 | -$0.39 | -$0.20 | 0.19 | N/A | $16.93 M |
| 11/07/2023 | Q3 2023 | -$0.55 | -$0.41 | 0.14 | N/A | $16.51 M |
| 08/10/2023 | Q2 2023 | -$0.51 | -$0.76 | -0.25 | N/A | $7.00 M |
| 05/08/2023 | Q1 2023 | -$0.64 | -$0.36 | 0.28 | N/A | $35.58 M |
| 03/07/2023 | Q4 2022 | $4.84 | $4.65 | -0.19 | N/A | $402.49 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.72 | N/A | N/A | $2.63 M |
| 08/04/2022 | Q2 2022 | -$0.93 | -$0.97 | -0.04 | N/A | $5.44 M |
| 05/04/2022 | Q1 2022 | -$0.97 | -$1.18 | -0.21 | N/A | $1.92 M |
| 05/02/2022 | Q4 2021 | N/A | -$0.76 | N/A | N/A | $19.87 M |
| 11/03/2021 | Q3 2021 | -$1.18 | -$1.17 | 0.01 | N/A | $4.40 M |
| 08/04/2021 | Q2 2021 | -$1.06 | -$1.31 | -0.25 | N/A | $1.77 M |
| 05/05/2021 | Q1 2021 | -$1.02 | -$0.87 | 0.15 | N/A | $644.00 K |
| 02/24/2021 | Q4 2020 | -$1.21 | -$0.74 | 0.47 | N/A | $15.68 M |
In the previous quarter, Zymeworks BC Inc (:ZYME) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.3 by $0.04.
The conference call for Zymeworks BC Inc's latest earnings report can be listened to online.
The conference call transcript for Zymeworks BC Inc's latest earnings report can be read online.
Zymeworks BC Inc (:ZYME) has a recorded annual revenue of $76.30 M.
Zymeworks BC Inc (:ZYME) has a recorded net income of $-122,695,000.Zymeworks BC Inc has generated $-1.62 earnings per share over the last four quarters.
Zymeworks BC Inc (:ZYME) has a price-to-earnings ratio of -26.89 and price/earnings-to-growth ratio is -2.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED